Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $662.8 million.

  • Phathom Pharmaceuticals' Total Liabilities rose 1544.3% to $662.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $662.8 million, marking a year-over-year increase of 1544.3%. This contributed to the annual value of $631.9 million for FY2024, which is 2985.96% up from last year.
  • According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Total Liabilities is $662.8 million, which was up 1544.3% from $656.1 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Total Liabilities high stood at $662.8 million for Q3 2025, and its period low was $111.0 million during Q1 2022.
  • For the 4-year period, Phathom Pharmaceuticals' Total Liabilities averaged around $415.9 million, with its median value being $486.6 million (2023).
  • In the last 5 years, Phathom Pharmaceuticals' Total Liabilities surged by 1156.58% in 2023 and then skyrocketed by 12536.69% in 2024.
  • Phathom Pharmaceuticals' Total Liabilities (Quarter) stood at $239.6 million in 2022, then skyrocketed by 103.07% to $486.6 million in 2023, then rose by 29.86% to $631.9 million in 2024, then grew by 4.89% to $662.8 million in 2025.
  • Its Total Liabilities was $662.8 million in Q3 2025, compared to $656.1 million in Q2 2025 and $632.6 million in Q1 2025.